8 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... molecular weight heparin ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... DOAC, direct oral ... low-molecular-weight heparin ... Anticoagulation #Management ... #Hematology #Oncology
Appearance of Liver Lesions on Various Imaging Modalities
 • Computed Tomography (CT) - Arterial Phase, Portal
Computed Tomography (CT ... Liver #Lesions #Hepatic ... #differential #diagnosis ... #comparison #table ... #appearance #hepatology
Approach to Thrombotic Microangiopathy (TMA) - Differential Diagnosis and Management Algorithm

Suspected TMA: Unexplained thrombocytopenia + MAHA
and Management ... hemoglobin/hemosiderin, Hepatic ... hemosiderin • PT/aPTT normal ... #Management #Algorithm ... #hematology
Appearance of Liver Lesions on Computed Tomography (CT) - Arterial Phase, Portal Venous Phase and Delayed
Computed Tomography (CT ... Arterial Phase, Portal ... #differential #diagnosis ... #comparison #table ... #appearance #hepatology
Algorithm regarding the diagnosis and treatment of Hereditary Hemochromatosis HH. 

Step 1: In the patient with
Algorithm regarding ... <45% and SF is normal ... including liver and hematologic ... hemochromatosis; HIC, hepatic ... #diagnosis #management
Algorithm for the diagnosis and management of iliofemoral deep vein thrombosis (DVT). In the absence of
Algorithm for the ... diagnosis and management ... thromboembolic disease, CT ... unfractionated heparin ... #dvt #vte #thromboembolism
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
products that define normal ... Mediastinal mass) • CT ... physical exam, CT ... classification #hematology ... #oncology #management